ProductNum | picture | CAS No. | Name and description | Size | Formula | Quick order |
---|---|---|---|---|---|---|
GC19513-5mg |
|
202284-87-5 |
N-tetradecanoyl-L-Homoserine lactone
|
0 | C18H33NO3 | |
GC19512-100mg |
|
439083-90-6 |
Bay 60-7550
|
0 | C₂₇H₃₂N₄O₄ | |
GC19512-10mg |
|
439083-90-6 |
Bay 60-7550
|
0 | C₂₇H₃₂N₄O₄ | |
GC19512-5mg |
|
439083-90-6 |
Bay 60-7550
|
0 | C₂₇H₃₂N₄O₄ | |
GC19512-10mM (in 1mL DMSO) |
|
439083-90-6 |
Bay 60-7550
|
0 | C₂₇H₃₂N₄O₄ | |
GC19511-100g |
|
113170-55-1 |
L-Ascorbic Acid 2-phosphate (magnesium salt)
|
0 | C6H6O9P • 1.5Mg | |
GC19511-10g |
|
113170-55-1 |
L-Ascorbic Acid 2-phosphate (magnesium salt)
|
0 | C6H6O9P • 1.5Mg | |
GC19511-5g |
|
113170-55-1 |
L-Ascorbic Acid 2-phosphate (magnesium salt)
|
0 | C6H6O9P • 1.5Mg | |
GC19510-50mg |
|
25526-93-6 |
Alovudine
|
0 | C10H13FN2O4 | |
GC19510-25mg |
|
25526-93-6 |
Alovudine
|
0 | C10H13FN2O4 | |
GC19509-25mg |
|
2230821-27-7 |
Gefitinib-based PROTAC 3
|
0 | C47H57ClFN7O8S | |
GC19509-5mg |
|
2230821-27-7 |
Gefitinib-based PROTAC 3
|
0 | C47H57ClFN7O8S | |
GC19509-1mg |
|
2230821-27-7 |
Gefitinib-based PROTAC 3
|
0 | C47H57ClFN7O8S | |
GC19508-25mg |
|
2141955-96-4 |
BLU-782
|
0 | C31H42N6O4 | |
GC19508-5mg |
|
2141955-96-4 |
BLU-782
|
0 | C31H42N6O4 | |
GC19508-1mg |
|
2141955-96-4 |
BLU-782
|
0 | C31H42N6O4 | |
GC19507-5mg |
|
2274819-46-2 |
LUT-014
|
0 | C27H19F3N8O | |
GC19506-10mg |
|
1044589-82-3 |
NITD008
|
0 | C₁₃H₁₄N₄O₄ | |
GC19506-5mg |
|
1044589-82-3 |
NITD008
|
0 | C₁₃H₁₄N₄O₄ | |
GC19506-1mg |
|
1044589-82-3 |
NITD008
|
0 | C₁₃H₁₄N₄O₄ | |